Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : John, Mike & Tom's Wild World of Stocks -- Ignore unavailable to you. Want to Upgrade?

To: wlheatmoon who wrote (952)	5/1/2000 12:22:00 PM
From: John Pitera	Read Replies (1) \| Respond to of 2850

That was an Interesting missive from the distant Bull Frontier. I bet people reading the piece on Galvin, were like folks living in Boston, in 1870....... Reading stories about Bison out on the great Plains -vbg- 90% equity allocation is pretty extreme for a Street House. I'm sure it's a Post WWII record.

To: wlheatmoon who wrote (952)	5/1/2000 2:56:00 PM
From: John Pitera	Read Replies (1) \| Respond to of 2850

PEB just mentioned on CNBC as the best company to be in for the next wave coming after Genomics, Proteiomics Kris Jenner who runs the T. Rowe Price Health Sciences fund told us what Mike and I know, that Proteiomics the science of manipulating Proteins to create therapies for diseases, will be one of the devlepoments of the decoding of the Human Genome. The French Scientists were doing Protein modifications for the treatment in last friday's NYT. Jenner, specifically mentioned the Mass Spectrometry equipment that PEB and WAT are making which is employed in this type of work. EPS Growth up 60% this past quarter and 256% over the last year. ---------------- PE Biosystems Group, one of two publicly traded subsidiaries of PE Corporation, manufactures instruments and other products used in life science research. Its Applied Biosystems unit makes instruments for nucleic acid synthesis, DNA sequencing, genetic analysis, and cellular detection. Its PerSeptive Biosystems unit makes instruments that purify, analyze, and synthesize proteins and related molecules; its PE Informatics unit develops bioinformatics software for the pharmaceutical, biotechnology, and agrochemical industries; and its Tropix unit manufactures chemiluminescent substrates and related products for life sciences markets. PE Biosystems also makes mass spectrometry instruments through its PE Sciex joint venture with MDS Health Group Limited. --- ----------------- PEB Earnings Numbers from First Call Growth Rates Earnings $ % 5 Yr Hist Latest Qtr. (Dec 99) .21 up 133% Latest 12 Months .72 up 34% 8% First Call Consensus Estimate LT Future Current Qtr. (Mar 00) .24 up 60% Yr. Ended Jun. 00 .85 up 57% 23% Yr. Ended Jun. 01 1.03 up 21